Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. / Kin Israel Notarte; Jesus Alfonso Catahay; Jacqueline Veronica Velasco [and others].
Material type:
ArticleLanguage: English Publisher: [Place of publication not identified] : Elsevier, 2022Description: 1 online resource (1 article)Content type: - text
- computer
- online resource
The source lists 13 contributors; the first 12 names are recorded as access points. The complete source author list is retained in the catalogue manifest.
Publication type: Journal article.
Linked open-access copy: published version.
Open access; no subscription required for the linked open-access version. Unrestricted online access star
Background Although COVID-19 vaccination decreases the risk of severe illness, it is unclear whether vaccine administration may impact the prevalence of long-COVID. The aim of this systematic review is to investigate the association between COVID-19 vaccination and long-COVID symptomatology. Methods MEDLINE, CINAHL, PubMed, EMBASE, and Web of Science databases, as well as medRxiv and bioRxiv preprint servers were searched up to June 20, 2022. Peer-reviewed studies or preprints monitoring multiple symptoms appearing after acute SARS-CoV-2 infection either before or after COVID-19 vaccination collected by personal, telephone or electronic interviews were included. The methodological quality of the studies was assessed using the Newcastle-Ottawa Scale. Findings From 2584 studies identified, 11 peer-reviewed studies and six preprints were included. The methodological quality of 82% ( n =14/17) studies was high. Six studies ( n =17,256,654 individuals) investigated the impact of vaccines before acute SARS-CoV-2 infection (vaccine-infection-long-COVID design). Overall, vaccination was associated with reduced risks or odds of long-COVID, with preliminary evidence suggesting that two doses are more effective than one dose. Eleven studies ( n =36,736 COVID-19 survivors) investigated changes in long-COVID symptoms after vaccination (infection-long-COVID-vaccine design). Seven articles showed an improvement in long-COVID symptoms at least one dose post-vaccination, while four studies reported no change or worsening in long-COVID symptoms after vaccination. Interpretation Low level of evidence (grade III, case-controls, cohort studies) suggests that vaccination before SARS-CoV-2 infection could reduce the risk of subsequent long-COVID. The impact of vaccination in people with existing long-COVID symptoms is still controversial, with some data showing changes in symptoms and others did not. These assumptions are limited to those vaccines used in the studies. Funding The LONG-COVID-EXP-CM study supported by a grant of Comunidad de Madrid.
Creative Commons Attribution (licence family recorded by the source; version not supplied in metadata).
https://europepmc.org/articles/PMC9417563
In English.
Description generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
Course allocation: B. Sc. Public Health.
There are no comments on this title.